The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
Autor: | Hwang, Jinah, Kleinhenz, Dean J., Rupnow, Heidi L., Campbell, Adam G., Thulé, Peter M., Sutliff, Roy L., Hart, C. Michael |
---|---|
Zdroj: | In Vascular Pharmacology 2007 46(6):456-462 |
Databáze: | ScienceDirect |
Externí odkaz: |